On the fly News and insights, exclusive to thefly.com

2018-02-13 10:19:17 JPM JPMorgan $111.25 / -0.489 (-0.44%) , TOT Ticker changed to TTE $56.20 / +0.48 (+0.86%) … 10:19 02/13/18 02/13 10:19 02/13/18 10:19	On The Fly: Top five analyst upgrades Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. JPMorgan (JPM) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying he views the recent pullback in the shares as a buying opportunity. 2. Total (TOT) upgraded to Overweight from Equal Weight at Morgan Stanley and to Strong Buy from Outperform at Raymond James. 3. Celgene (CELG) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying the current valuation largely reflects the risk. 4. Quest Diagnostics (DGX) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying he believes the company has "substantial runway on several fronts," including its Optum partnership related to revenue cycle management, which he believes could reduce bad debts and claims denials. 5. Boeing (BA) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. JPM JPMorgan $111.25 / -0.489 (-0.44%) TOT Ticker changed to TTE $56.20 / +0.48 (+0.86%) CELG Bought by BMY $91.51 / -1 (-1.08%) DGX Quest Diagnostics $100.25 / +1.18 (+1.19%) BA Boeing $342.21 / -1.59 (-0.46%)	16 Feb 17 Feb 21 Feb 21 Feb 27 Feb 07 Mar 08 Mar 09 Mar 13 Mar 25 Mar 13 Apr 30 May 13 Jul 12 Oct

2018-02-13 10:19:17

JPM

JPMorgan

$111.25 / -0.489 (-0.44%)

, TOT

Ticker changed to TTE

$56.20 / +0.48 (+0.86%)

… 10:19

02/13/18

02/13

10:19

02/13/18

10:19

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. JPMorgan (JPM) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying he views the recent pullback in the shares as a buying opportunity. 2. Total (TOT) upgraded to Overweight from Equal Weight at Morgan Stanley and to Strong Buy from Outperform at Raymond James. 3. Celgene (CELG) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying the current valuation largely reflects the risk. 4. Quest Diagnostics (DGX) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying he believes the company has "substantial runway on several fronts," including its Optum partnership related to revenue cycle management, which he believes could reduce bad debts and claims denials. 5. Boeing (BA) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

JPM

JPMorgan